Article
Molecular and phenotypic heterogeneity of metastatic prostate cancer.
Cancer biology & therapy - 1 Feb 2005
Chau Cindy H, Figg William D
Abstract excerpt
Metastatic prostate cancer remains a prevalent disease in the United States that requires detailed characterization of its pathobiology. In the December 2004 issue of Cancer Research, a comprehensive study by Shah et al. demonstrated that metastatic androgen-independent prostate cancer is a collective group of diseases even within the same patient. Understanding the molecular and phenotypic determinants of this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
